neuroblastoma
Recurrent alterations at relapse included mutations in the putative CHD5 neuroblastoma tumor suppressor, chromosome 9p losses, DOCK8 mutations, inactivating mutations in PTPN14 and a relapse-specific activity pattern for the PTPN14 target YAP.
Recurrent alterations at relapse included mutations in the putative <span class="gene" id="26121086-6-68-72">CHD5</span> <span class="disease" id="26121086-6-73-86">neuroblastoma</span> tumor suppressor, chromosome 9p losses, DOCK8 mutations, inactivating mutations in PTPN14 and a relapse-specific activity pattern for the PTPN14 target YAP.